GHB analogs confer neuroprotection through specific interaction with the CaMKII hub domain
Ontology highlight
ABSTRACT: Ca2+/calmodulin-dependent protein kinase II alpha (CaMK2A) is an emerging drug target incerebral ischemia for which limited therapeutic options exist. Here we show that small-molecule analogs of the brain metabolite gamma-hydroxybutyric acid (GHB) afford neuroprotection via interaction specifically with the CaMK2A hub domain. Identification of CaMK2A as the GHB analog target was achieved by homogenate photoaffinity labeling followed by quantitative proteomics
INSTRUMENT(S): Q Exactive HF
ORGANISM(S): Rattus Norvegicus (rat)
TISSUE(S): Brain
SUBMITTER: Ulrike Leurs
LAB HEAD: Jesper V. Olsen
PROVIDER: PXD019679 | Pride | 2021-07-22
REPOSITORIES: Pride
ACCESS DATA